A Study of AK146D1 for Injection in Advanced Solid Tumors

Summary

This is an first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK146D1 for injection in advanced solid tumors.

Timeline

Start

2025-08-07

Primary completion

2026-11-05

Completion

2027-05-05

Drugs

Indications